🇺🇸 FDA
Patent

US 7195876

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

granted A61PA61P35/00A61P43/00

Quick answer

US patent 7195876 (Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same) held by Theravance, Inc. expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P35/00, A61P43/00